Sudden Cardiac Death Syndrome and Pump Dysfunction: The Link

Journal of Heart and Lung Transplantation

Volumn 19, Issue 8, 2000, Pages

  Young, James B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART AUTOMATICITY; HEART BLOCK; HEART FAILURE; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; SYNCOPE;

EID: 0034632651     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1053-2498(99)00109-6     Document Type: Article

References (32)

1. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995;26:1376-98.
2. Deedwania PC. Ventricular arrhythmias in heart failure: to treat or not to treat? Cardiol Clin 1994;12:115-32.
3. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993;88:2953-61.
4. Stevenson WG, Middlekauff HR, Saxon LA. Ventricular arrhythmias in heart failure. In: Zipes DP and Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders, 1994.
5. Guindo J, Genis Bayes A, Dominguez de Rozas JM, Fiol M, Vinolas X, de Luna A Bayes. Sudden death in heart failure. Heart Failure Rev 1996;1:249-60.
6. Young JB. Clinical trials with implications regarding heart failure therapy. Curr Opinion Cardiol 1997;12:407-17.
7. Aronson RS. Mechanisms of arrhythmias in ventricular hypertrophy. J Cardiovas Electrophysiol 1991;2:249-61.
8. Hansen DE, Borganelli M, Stacy GP, et al. Dose-dependent inhibition of stretch-induced arrhythmias by gadolinium in isolated canine ventricles. Evidence for a unique mode of antiarrhythmic action. Circ Res 1991;69:820-31.
9. Gettes LS. Electrolyte abnormalities underlying lethal ventricular arrhythmias. Circulation 1992;I:70-6.
10. Packer M, Lee WH. Provocation of hyper- and hypokalemic sudden death during treatment with and withdrawal of converting enzyme inhibition in severe chronic congestive heart failure. Am J Cardiol 1986;57:347-8.
11. Chakko SC, Frutchey J, Gheorghiade M. Life-threatening hyperkalemia in severe heart failure. Am Heart J 1989;117: 1803.
12. Koilpillai C, Quinones MA, Greenberg B, et al. Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol 1996;77:606-11.
13. Pratt CM, Greenwang PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation 1996;93:519-24.
14. Gottlieb SS. Dead is dead; artificial definitions are no substitute. Lancet 1997;349:662-3.
15. Simon SR, Power LH, Bartzokis TC, Hoch DH. A new system for classification of cardiac death as arrhythmic, ischemic, or due to myocardial pump failure. Am J Cardiol 1995;76:896-989.
16. Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ. Classification of death in antiarrhythmic trials. J Am Coll Cardiol 1996;27:433-42.
17. Burggraf GW, Parker JO. Prognosis in coronary artery disease: angiographic, hemodynamic and clinical factors. Circulation 1975;51:146-56.
18. Massie B, Pabs T, Chatterjee K, et al. Long-term vasodlator therapy for heart failure: clinical response and its relationship to hemodynamic measurement. Circulation 1981;63:269-78.
19. Franciosa JA. Why patients with heart failure die: hemodynamic and functional determinants of survival. Circulation 1987;75:IV20-7.
20. Huang SK, Messer JV, Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol 1983;51:507-12.
21. Wilson JR, Schwarte JS, Sutton MSJ, et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983;2: 403-10.
22. Cohn JN, Levin TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
23. Lee WH, Packer M. Prognostic value of serum sodium concentration in severe heart failure and its modification by converting-enzyme inhibition. Circulation 1984;70:11-114.
24. Meinertz T, Hofmann T, Kasper W, et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984;53:902-7.
25. Holmes J, Kubo SH, Cody RJ, et al. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985; 55:146-51.
26. Francis GS. Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence, and prognosis. Am J Cardiol 1986;57:3B-7B.
27. Dargie HJ, Cleland JGF, Leckie BJ, et al. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 1987;75: IV98-IV107.
28. Cohn JN, Archibald DF, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study. N Engl J Med 1986;314:1547-52.
29. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure (VeHeft-II). N Engl J Med 1991;325:303-10.
30. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
31. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
32. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.